NE-RSV vaccine (BlueWillow/Merck)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNE-RSV vaccine (BlueWillow/Merck)
Drug Alias NameNE-RSV vaccine (NanoBio/Merck)RSV virus vaccine (BlueWillow/Merck & Co)RSV virus vaccine (NanoBio/Merck & Co)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBluewillow Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncBluewillow Biologics Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A